首页 | 本学科首页   官方微博 | 高级检索  
     


Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts
Authors:Gong Jianlin  Koido Shigeo  Kato Yoko  Tanaka Yasuhiro  Chen Dongshu  Jonas Anna  Galinsky Ilene  DeAngelo Daniel  Avigan David  Kufe Donald  Stone Richard
Affiliation:

a Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA

b Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA

Abstract:Presentation of AML antigens by dendritic cells (DC) could potentially induce a T cell-mediated anti-leukemic immune response. In the present study, we generated DC from adherent (AD-DC) and non-adherent (NAD-DC) myeloblasts obtained from bone marrows of AML patients. Both cell populations displayed morphological, phenotypic and functional properties of DC. The functions of NAD-DC were compared to AD-DC that had been fused with autologous AML blasts (FC/AML). The FC/AML induced greater T cell proliferation and CTL activity against autologous AML blasts (9/10 cases) as compared to NAD-DC. FC/AML may thus represent a promising strategy for DC-based immunotherapy of patients with AML.
Keywords:Generation of dendritic cells   Fusion of autologous DC and AML blasts   Autologous T cell proliferation   Anti-leukemia immunity
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号